Millstone Evans Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.96K Buy
+78
New +$3.6K ﹤0.01% 750

Other funds holding NVO

Millstone Evans Group's NVO Position: Q3 2026 in Review

Millstone Evans Group opened a new position in Novo Nordisk (NVO) in Q3 2026: 78 shares worth $2.96K. The stake represents ﹤0.01% of the portfolio and ranks #750 among its holdings.

1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Millstone Evans Group held 78 shares of Novo Nordisk worth $2.96K as of Q3 2026.
  • Novo Nordisk was a new Millstone Evans Group position in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Millstone Evans Group's portfolio in Q3 2026, its #750 holding.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Millstone Evans Group's 13F filing for Q3 2026, filed 12 Nov 2026.